Suman Garlapati's Email & Phone Number

💼 Past Experience

Dr. Suman Garlapati has an backgrounds in Pharmaceutical Research, Pharmacovigilance, and Safety and Sustainability. He has over 15 years of experience in Pharmaceutical Research, Pharmacovigilance, and Safety and Sustainability. Dr. Suman Garlapati is currently a CEO at 3R Biopharma, LLC, a subsidiary of Novartis, and a Senior Pharmacovigilance Consultant at ARIAD Pharmaceuticals, Inc. from February 2015 to July 2015. He also has a background in Safety andbenefit risk management from February 2014 to January 2015 at Biogen. He also has a background in Genomics from July 2009 to September 2013 at Basavatarakam Indo-American Cancer Hospital and a background in R&D from April 2006 to May 2009 at Mahavir Hospitals & Reseach Center. He is also a Sr. Research Associate at Mahavir Hospitals & Reseach Center.Dr. Suman Garlapati has experience in role of Head, Drug Safety & Pharmacovigilance, at InvaGen Pharmaceuticals Inc. from July 2009 to September 2013. He also has experience as Head, Genomics Division, R&D at Basavatarakam Indo-American Cancer Hospital from April 2006 to May 2009. He has experience as Sr. Research Associate at Mahavir Hospitals & Reseach Center.

🎓 Education

Dr. Suman Garlapati has a B.Sc. in experimental biology from Madurai Kamaraj University, India. After completing his undergraduate studies, Dr. Garlapati got a M.Sc. in biotechnology from Bharathidasan University, Trichy, TN, India. After completing his M.Sc., Dr. Garlapati moved to the School of Life Sciences, University of Mysore, Mysore, India, to study for his Ph.D. in biotechnology. Upon completion of his doctorate, Dr. Garlapati will serve as an assistant professor at the School of Life Sciences at the University of Mysore, Mysore, India.

💡 Technical & Interpersonal Skills

Dr. Suman Garlapati has over 10 years of experience in the Pharmaceutical and Biotech industries. In his previous positions, Dr. Garlapati has worked extensively in the field of safety and benefit risk management for global pharmaceutical companies, as well as developing and overseeing drug development at Basavatarakam Indo-American Cancer Hospital and Mahavir Hospitals & Reseach Center. He has also held a number of lead or key project roles within the Drug Safety and Pharmacovigilance Directorate at InvaGen Pharmaceuticals Inc.Dr. Garlapati is a highly experienced scientist and has a great understanding of both the science behind drugs and their safety and protection. His experience in safety and benefit risk management has helped him manage complex drug development tasks, and he isSkilled in communicating with bothclinical and piratical partners. Dr. Garlapati is a highly effective team player, and he is a greatرالاتومیةىكى التحرک بالراحلة الدولیة العربیة